Cargando…
In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K(v)10.1
The K(v)10.1 (Eag1) voltage-gated potassium channel represents a promising molecular target for novel cancer therapies or diagnostic purposes. Physiologically, it is only expressed in the brain, but it was found overexpressed in more than 70 % of tumours of diverse origin. Furthermore, as a plasma m...
Autores principales: | Napp, Joanna, Pardo, Luis A., Hartung, Franziska, Tietze, Lutz F., Stühmer, Walter, Alves, Frauke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045485/ https://www.ncbi.nlm.nih.gov/pubmed/27444284 http://dx.doi.org/10.1007/s00249-016-1152-z |
Ejemplares similares
-
Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody
por: Hartung, Franziska, et al.
Publicado: (2011) -
Rapid Internalization of the Oncogenic K(+) Channel K(V)10.1
por: Kohl, Tobias, et al.
Publicado: (2011) -
Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
por: Hartung, Franziska, et al.
Publicado: (2016) -
Functional K(V)10.1 Channels Localize to the Inner Nuclear Membrane
por: Chen, Ye, et al.
Publicado: (2011) -
Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival
por: Martínez, Ramón, et al.
Publicado: (2015)